These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12695282)

  • 1. Gap between clinical trials and clinical practice: lessons from the Bypass Angioplasty Revascularization Investigation (BARI).
    Frye RL; Brooks MM; Nesto RW;
    Circulation; 2003 Apr; 107(14):1837-9. PubMed ID: 12695282
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database.
    McGuire DK; Anstrom KJ; Peterson ED
    Circulation; 2003 Apr; 107(14):1864-70. PubMed ID: 12668513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of coronary artery disease in the year 2003.
    Fleisher LA; Barash PG
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):258-9. PubMed ID: 12698413
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
    Schwartz L; Kip KE; Alderman E; Lu J; Bates ER; Srinivas V; Bach RG; Mighton LD; Feit F; King S; Frye RL;
    Am J Cardiol; 2009 Mar; 103(5):632-8. PubMed ID: 19231325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ever increasing role of percutaneous interventions in coronary revascularisation.
    Spanos VN; Toutouzas PK
    Hellenic J Cardiol; 2010; 51(6):512-7. PubMed ID: 21169183
    [No Abstract]   [Full Text] [Related]  

  • 7. General cardiology perspective: decision making regarding revascularization of patients with type 2 diabetes mellitus and cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Fuster V; Farkouh ME
    Circulation; 2010 Jun; 121(22):2450-2. PubMed ID: 20530023
    [No Abstract]   [Full Text] [Related]  

  • 8. [The BARI 2D study].
    Mafrici A; Briguori C
    G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772
    [No Abstract]   [Full Text] [Related]  

  • 9. How to revascularize patients with diabetes mellitus: bypass or stents and drugs?
    Elsässer A; Möllmann H; Nef HM; Hamm CW
    Clin Res Cardiol; 2006 Apr; 95(4):195-203. PubMed ID: 16598587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
    Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do hybrid procedures have proven clinical utility and are they the wave of the future? : hybrid procedures have no proven clinical utility and are not the wave of the future.
    Leacche M; Zhao DX; Umakanthan R; Byrne JG
    Circulation; 2012 May; 125(20):2504-10; discussion 2510. PubMed ID: 22615421
    [No Abstract]   [Full Text] [Related]  

  • 13. Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).
    Alderman EL; Kip KE; Whitlow PL; Bashore T; Fortin D; Bourassa MG; Lesperance J; Schwartz L; Stadius M;
    J Am Coll Cardiol; 2004 Aug; 44(4):766-74. PubMed ID: 15312856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statement of the problem.
    Steiner G;
    Am J Cardiol; 2006 Jun; 97(12A):3G-8G. PubMed ID: 16813733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Barsness GW; Gersh BJ; Brooks MM; Frye RL;
    Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical versus percutaneous revascularization of coronary artery disease in diabetic patients.
    Cook S; Windecker S
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):317-34. PubMed ID: 19520306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Magee MF; Isley WL;
    Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Editorial comment: distribution of therapeutic procedures and drug selection in coronary artery disease].
    Akgün G
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):24-5. PubMed ID: 12793430
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to myocardial revascularization procedures: closing the gap with time?
    Vanasse A; Niyonsenga T; Courteau J; Hemiari A
    BMC Public Health; 2006 Mar; 6():60. PubMed ID: 16524458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease.
    Davierwala PM; Mohr FW
    Curr Atheroscler Rep; 2014 Dec; 16(12):461. PubMed ID: 25344743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.